SCHEMBL3335254

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3339427	0.89	AR (0.55)	ARALDH1A1
	SCHEMBL3338918	0.81	AR (0.51)	ARLRRK2
	SCHEMBL3337979	0.81	AR (0.57)	ARCHRM2USP14KDM1AGPR119
	SCHEMBL3334771	0.77	AR (0.49)	ARCHRM2USP14LRRK2TRPV4
	SCHEMBL3337735	0.77	AR (0.64)	AR
	SCHEMBL3334458	0.76	AR (0.47)	ARLRRK2
	SCHEMBL3336707	0.76	AR (0.48)	ARLRRK2ALDH1A1GPR119
	SCHEMBL3333009	0.76	AR (0.54)	AR
	SCHEMBL3336405	0.75	AR (0.56)	ARALDH1A1
	SCHEMBL13303258	0.75	AR (0.56)	ARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.